InvestorsHub Logo
Followers 125
Posts 7319
Boards Moderated 1
Alias Born 12/03/2017

Re: Dyno89 post# 187692

Thursday, 10/05/2023 1:05:28 PM

Thursday, October 05, 2023 1:05:28 PM

Post# of 198306
Dyno, I used very simple math and a basic calculation to arrive at 0.30. In other words, I basically took 10% of the projected value of Clone 3 only. If Clone 3 is projected at roughly $9.09B per year, that puts ENZC pps over $3.00. Since pre-trial/pre-results, most Bio's are priced somewhere between true value & projected value, I took the lower of 10% to arrive at $0.30. It was much easier to do this, then to get into the thick of it with projected value for each item (C3, C7, ai, ITV1, etc....).

Just not sure why ENZC isn't following the pricing model of the majority of other pre-trial/pre-resluts bios. $0.03 is an absolute joke.